Medical ML Regulatory Landscape for Medical AI: FDA, CE Marking, and Ukrainian MHSU

Key Points

• The central aim is to analyze the regulatory frameworks governing medical AI across varying regions, including the FDA and CE marking.
• Review of existing regulations for medical AI from the FDA and CE marking systems.
• Analysis of the regulatory approach in Ukrainian healthcare systems.
• Comparison of regulatory strategies to understand implications for medical AI deployment.
• Identification of key regulatory differences between FDA and CE marking processes.
• Insights into the unique regulatory challenges faced by Ukrainian MHSU in adopting medical AI.
• Recommendations for harmonizing regulations to facilitate broader adoption of medical AI technologies.